The increasingly dynamic fine chemicals market continues to recognize the strategic value of multi-functional building blocks, with 2-Ethylbutylamine emerging as a key driver in value-chain innovation. Forecasts for the 2026 procurement cycle indicate that bulk pricing for this alkylamine will range between $49 and $68 per kilogram depending on purity and order volume. This pricing is shaped by several intertwined factors: persistent volatility in the upstream petrochemical feedstocks, heightened regulatory obligations under UN Hazard Class 3 protocols, and intense competition among major global suppliers. Pharmaceutical-grade quality control, in particular, is subject to rigorous analytical scrutiny, with full compliance to international standards now table stakes for market entry. The industry imperative is clear: organizations seeking to ensure secure, price-efficient sourcing must adopt a data-driven, compliance-centric approach grounded in both supplier diversification and technical specification clarity.
The global market for 2-Ethylbutylamine, also commonly referred to as 2-ethyl-1-butanamine, sec-butyl ethylamine, or ethylbutan-2-ylamine, has rapidly accelerated in the context of fine chemical synthesis. Registered under CAS number 110-41-8 and featuring a molecular formula of C6H15N, this secondary amine is prized for its versatility across multiple organic transformations, especially where chiral scaffolds or custom amide linkers are required. Versatile reactivity is attributed to the molecule’s balanced nucleophilicity and moderate steric profile, which lend themselves to reductive amination, alkylation, and salt formation in pharmaceutical intermediates, crop protection agents, and specialty polymers. As a recognized substance regulated under UN Hazard Class 3 (flammable liquids), 2-Ethylbutylamine’s logistical profile must be integrated into any comprehensive market analysis. The presence of major industry participants—including NINGBO INNO PHARMCHEM CO.,LTD., Alfa Aesar, and BASF SE—underscores a consolidating landscape in which technical purity, supplier validation, and shipping compliance are core differentiators. Against this backdrop, purchasers in 2026 will need both granular chemical insight and up-to-date pricing intelligence to navigate the complexities of bulk procurement.
Price structures for 2-Ethylbutylamine in 2026 will be most impacted by three overlapping market dynamics. The first and perhaps most influential is volatility in upstream suppliers of starting materials, notably 1-butanol and ethylamine, as well as critical reagents such as sodium cyanide and metallic hydrogenation catalysts. These commodities have demonstrated price elasticity in response to global energy trends and regional supply-chain interruptions, particularly in Asia. Pharmaceutical demand for 2-Ethylbutylamine surged in the last 18 months, with custom synthesis and contract research organizations specifying higher-purity batches to meet regulatory submissions in both the U.S. and Europe. This trend is expected to persist as next-generation APIs and advanced intermediates rise in complexity, driving new applications for this amine. On the logistics and compliance front, UN Hazard Class 3 status elevates shipping costs, mandates UN-certified packaging, and necessitates regular staff training on chemical handling. Notably, instances of container reclassification and port inspection delays have increased total landed costs by as much as 7% in certain markets. Compounding these pressures is the ongoing consolidation among Chinese manufacturers, with regional leaders such as NINGBO INNO PHARMCHEM CO.,LTD. integrating vertically and building out compliance capacity, while international suppliers like Alfa Aesar and BASF SE target higher-margin, pharmaceutical-validated volumes.
In the context of bulk quotation, three factors consistently shape cost and supply risk for 2-Ethylbutylamine: achievable purity, order volume, and logistical complexity. Technical specification remains paramount. Most buyers will encounter two prevailing purity bands: ≥98% (industrial grade) and ≥99% (pharmaceutical grade). The latter is validated using a suite of analytical methods, including gas chromatography (GC), high-performance liquid chromatography (HPLC), and residual solvent testing in line with ICH Q3C guidelines. Heavy metal content, a growing concern for end-users in life sciences, is typically monitored to sub-ppm levels, with Certificates of Analysis now standard in all B2B transactions. Industrial grade product, while suitable for polymer synthesis or agrochemical intermediates, frequently involves broader impurities and is subject to less rigorous release testing.
Order volume exerts powerful leverage on landed cost. Buyers requesting 1 to 10 kilograms of ≥98% purity 2-Ethylbutylamine in 2026 should anticipate prices in the $68 per kilogram range, with an expected lead time of one to one and a half weeks. Scaling to 25 to 100 kilograms, the price decreases to approximately $61 per kilogram, and delivery times lengthen modestly to two weeks. Pharmaceutical buyers requiring ≥99% purity and volumes between 100 and 500 kilograms can expect quotations in the $55 per kilogram range with lead times extending up to 20 days, reflecting both batch scheduling and increased quality testing. The lowest published pricing occurs at the 1,000 kilogram mark or higher, with leading Chinese suppliers offering $49 per kilogram, typically with batch-specific documentation and a lead time of 25 to 35 days to accommodate compliance and consolidated freight.
Shipping and regulatory compliance have become inextricable from the procurement of hazardous organic amines. Suppliers serving the EU and North America must demonstrate conformity with the European REACH regulation, the U.S. TSCA reporting standards, and the GHS labeling system, all of which extend to packaging, documentation, and digital safety data sheet delivery. UN-certified drums and composite intermediate bulk containers are standard, with tamper-evident seals now universally employed. Pre-shipment sample retention and third-party stability testing, particularly for pharmaceutical and specialty chemical accounts, are increasingly non-negotiable. Buyers should account for any additional fees associated with seasonal port restrictions or export permit renewal, both of which can have a disproportionate impact on landed cost for Just-in-Time (JIT) supply chains.
Securing competitive quotations from verified suppliers requires a methodical approach. It is essential to begin by specifying technical requirements in detail within the initial request for quotation (RFQ). This encompasses the CAS number (110-41-8), molecular formula (C6H15N), target purity (≥98% or ≥99%), packaging format (such as UN-rated steel drum or HDPE carboy), and all ancillary documentation, including but not limited to updated Certificates of Analysis, batch stability data, and unique lot identification. Only after this step should buyers invite simultaneous quotations from at least three suppliers to ensure pricing transparency and comparable fulfillment terms. Here, the participation of established players such as NINGBO INNO PHARMCHEM CO.,LTD., Alfa Aesar, and BASF SE provides both a benchmark for compliance expectations and a degree of risk mitigation in terms of supply resilience. Throughout the negotiation, insistence on recent CoA, comprehensive SDS, and up-to-date stability data is essential for all life-science and food-contact applications. For those seeking further details on validated pharmaceutical-grade batches and current certifications, reference can be made to the dedicated product resource at Versatile Reactivity of 2-Ethylbutylamine in Fine Chemical Synthesis.
In summary, strategic sourcing of high-purity Versatile Reactivity of 2-Ethylbutylamine in Fine Chemical Synthesis for the 2026 purchasing cycle hinges on a nuanced understanding of both technical and market dynamics. The continued upward trajectory of pharmaceutical and specialty intermediate demand is likely to create pockets of supply tightness, particularly for documentation-intensive consignments. While the lowest cost per kilogram can be achieved via large-volume, direct-from-manufacturer orders, these arrangements necessitate an up-front investment in supplier qualification, particularly around regulatory compliance and batch traceability. Buyers are encouraged to actively monitor both upstream raw material indices and region-specific compliance changes, including any amendments under ICH Q3C or new obligations for hazardous packaging. Companies that cultivate a robust supplier network—balancing established partners such as NINGBO INNO PHARMCHEM CO.,LTD. with capable global competitors—will be positioned to capitalize on volume-based discounts, minimize regulatory risk, and secure uninterrupted access to this versatile amine. By applying data-driven procurement practices and emphasizing quality assurance at every stage, organizations can confidently navigate the complex terrain of 2-Ethylbutylamine bulk supply in 2026 and beyond.
Related Articles
